What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Ampule

Neclar INJ

Diclofenac Sodium 75mg

Pack: 1ML
Format: Ampule

MRP₹18.75

A potent non-steroidal anti-inflammatory drug (NSAID) injection formulated for the rapid relief of acute pain and inflammation. Neclar INJ contains Diclofenac Sodium 75mg, providing high-speed systemic delivery to manage severe musculoskeletal pain and post-operative distress.

About The Product

Key Benefits

Rapid Prostaglandin Synthesis Inhibition

Diclofenac Sodium 75mg works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2). This action blocks the production of prostaglandins, the primary chemical mediators responsible for pain, fever, and inflammatory swelling.

Immediate Systemic Analgesia

The injectable delivery ensures 100% bioavailability, bypassing the digestive tract for a significantly faster onset of action compared to oral tablets. This is critical for patients requiring emergency relief from high-intensity pain.

Potent Anti-Inflammatory Efficacy

Beyond simple pain relief, Neclar INJ targets the site of tissue injury to reduce localized edema and redness. It is highly effective in treating acute flares of chronic inflammatory conditions like rheumatoid arthritis and gout.

Management of Renal and Biliary Colic

The formulation is a frontline choice for the management of ureteric and biliary colic. Its ability to reduce muscle wall tension and inhibit localized inflammation provides superior relief from the sharp, radiating pain associated with stones.

Post-Surgical Pain Stabilization

Administered in clinical settings, this injection serves as an effective tool for managing post-operative pain. By providing early analgesic coverage, it reduces the patient's reliance on opioid-based medications and facilitates faster mobilization.

Optimized Pharmacokinetic Profile

The 75mg dose is carefully balanced to provide maximum therapeutic impact with a minimized risk of systemic side effects. It maintains steady plasma concentrations to ensure the patient remains comfortable during the acute phase of recovery.

Indication Acute Musculoskeletal Pain, Renal and Biliary Colic, Post-Operative Pain Management, Rheumatoid Arthritis and Osteoarthritis Flares, Acute Gouty Arthritis, Severe Migraine Attacks.

Indications

Acute Musculoskeletal Pain
Renal and Biliary Colic
Post-Operative Pain Management
Rheumatoid Arthritis and Osteoarthritis Flares
Acute Gouty Arthritis
Severe Migraine Attacks.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Neclar INJ